Register today to attend Decentralized Clinical Trials Digital week, a free-to-attend clinical webinar series. The series will feature the current state of decentralized trials and how the impact of COVID-19 is accelerating collaboration to adopt decentralized trials. To find out more about future sponsorship opportunities, please contact partners@informaconnectls.com

DAY 1 – 15 November 2021



How the Rise of Today's Agile Clinical Trials Will Continue to Disrupt the Industry, and What You Can Do to Get Ready
2:00pm GMT / 3:00pm CET / 9:00am EST

We’re seeing the future in today’s agile clinical trial—bringing together traditional and decentralized execution in a multitude of indications. No two clinical trials are the same and executing them successfully will demand sophisticated technology and operational agility.

But don’t just take our word for it …

In this session, Science 37’s Chief Delivery Officer Darcy Forman will draw on our brand-new research, revealing how biopharma companies and other sponsors are planning their clinical trial activity for the next 12 months (and vs. the previous year), including:

  • Overall adoption trends of DCT, including fully decentralized studies and various hybrid configurations
  • Plans to deploy DCT, by therapeutic category and study phase, for the coming year
  • Use trends for individual DCT components and networks over time
  • Rankings of perceived challenges and opportunities in DCT

Join us to explore these valuable insights, along with many other observations and projections.

Speaker:

Darcy Forman
Chief Delivery Officer
Science 37

View More Details +

Patient Pioneering – How Technology Holds the Key to Diverse Representation and a Retention-boosting Patient Experience
3:00pm GMT / 4:00 pm CET / 10:00am EST

  • There are many reasons for patients dropping out of studies. Some are easy to avoid: travel difficulties, financial challenges, pressure of work-life commitments - essentially the burden of participation.
  • We look at how today’s smartphone and wearable technology can combine with smart thinking, delivering better data and a more compassionate and immersive patient experience.
  • Discover how innovative door-to-door travel management and rapid reimbursement enables sites to recruit from further afield, accessing parts of the community previously thought off limits.

Speaker:

Chris Wells
Senior Director of Patient Concierge
Illingworth Research Group

View More Details +

The Role of Technology in Increasing Patient Completion Rates: Insights from a Decentralized Women's Health Medical Device Trial
4:00pm GMT / 5:00 pm CET / 11:00am EST

Renovia , an innovative digital therapeutics company dedicated to improving women’s Pelvic Floor Health collaborated with Obvio Health, their decentralized Clinical Trial partner, to test the efficacy of an at-home pelvic digital health system (PDHS) for the treatment of women with stress and mixed urinary incontinence when compared to the current standard of care. The 8 week randomized study amongst 350 women in the US was conducted virtually using a downloadable app to report on symptoms while also capturing actual device use. This enabled the virtual team to closely track progress, measure adherence and engage with participants accordingly. Sponsor and CRO will discuss the findings and the implications for study design going forward.

Speakers:

Matty Culbreth Notaro
Chief Operating Officer
Obvio Health

Robin Sutherland
Vice President of Human Resources and Clinical Operations
Renovia

View More Details +

The New Research Ecosystem Enabled by DCT Adoption
5:00pm GMT / 6:00 pm CET / 12:00 pm EST

  • Virtual clinical trials are the future of building quick market brand understanding
  • The most cost-efficient way to create experience sharing
  • Should you plan virtual trials for new launches
  • How compliance will change in the future?
  • Why it is important to build RWE trials for your brand?

Speaker:

Craig Lipset
Founder & Advisor
Clinical Innovation Partners, USA
Co-Chair
Decentralized Trials & Research Alliance (DTRA)

View More Details +

DAY 2 – 16 November 2021



Patient Centricity in Practice
2:00pm GMT / 3:00pm CET / 9:00am EST

Patients are savvier and more engaged than ever before in their healthcare. As the biopharma industry strives to deliver more patient-centric decentralized clinical trials (DCTs), a design thinking approach can help sponsors more purposefully identify and deploy the trial models and technologies that most enhance patients’ experience.

In this webinar, IQVIA experts will share how to put patient-centricity into practice. Reconsider common assumptions by gathering insight into patients’ needs and experiences before protocol design. Improve study outcomes by applying those insights to strategically inform the right DCT study model and technologies for your study.

The result? Higher retention, improved engagement, and faster, higher quality study results.

Speakers:

Krista Bradley
RN, MBA, Vice President and General Manager
IQVIA Research Nursing and Phlebotomy Solutions

Melissa Easy
Vice President Clinical Technologies
IQVIA R&D Solutions

Kelly Sanford
Global Head of Site Operations
IQVIA Decentralized Trials Solutions

View More Details +

Virtual, Distributed, or Mobile: DCT Strategies to Reach More Patients, Contain Costs, and Enroll Faster
3:00pm GMT / 4:00 pm CET / 10:00am EST

85% of all clinical trials fail to meet their enrollment goals. This talk will....

  • examine the issues and common factors that prolong enrollment in most clinical trials today.
  • explore how removing the constraints imposed by traditional approaches to running clinical trials opens up possibilities that would not otherwise be available and;
  • share examples of how new approaches have helped to compress enrollment timelines and increase diversity in clinical trials.

Speaker:

Ahmad Namvargolian
Chief Executive Officer and Co-founder
Care Access

View More Details +

How Can Virtual Trials Accelerate Commercial Operation?
4:00pm GMT / 5:00 pm CET / 11:00 am EST

  • Virtual clinical trials are the future of building quick market brand understanding
  • The most cost-efficient way to create experience sharing
  • Should you plan virtual trials for new launches
  • How compliance will change in the future?
  • Why it is important to build RWE trials for your brand?

Speaker:

Mohanad Fors
Head of Global Digital Innovation
Almirall LLC

View More Details +

DAY 3 – 17 NOVEMBER 2021



Best Practices for Global DCT Adoption
2:00pm GMT / 3:00pm CET / 9:00am EST

In this session, John Reites, CEO at THREAD will share his perspectives and best practices focused on scaled adoption of decentralized clinical trial approaches. Topics include:

  1. Global implementation
  2. How to move beyond pilots
  3. The convergence of DCT technology and real-world data
  4. The use of analytics to prove out the value proposition of DCT
  5. The importance of working closely with research ambassador teams, participants & sites to enable change management.

Speaker:

John Reites
CEO
THREAD

View More Details +

DCT - Drugs. Sites. Patients: the technology behind the scenes, a panel discussion hosted by 4G Clinical
3:00pm GMT / 4:00 pm CET / 10:00am EST

  • Discuss a holistic DCT workflow from patient recruitment to dispensation, drug integrity and delivery
  • Examine the patient experience today in the context of a modern, connected world
  • Analyze how technology supports the end-to-end patient experience, quality and compliance
  • Consider the implications of the DCT model on clinical research sites
  • Evaluate current challenges and discuss best practices for moving forward
  • Discover how end-to-end innovations in technology is critical for successful DCT trials

Speakers:

Neta Bendelac
Senior Director, Strategy
4G Clinical

Libbi Rickenbacher
Director, Strategy
4G Clinical

Andrea Zobel
Senior Director
Personalized Supply Chain
World Courier

Joss Warren
Executive Director
Head of Strategy and Partnerships
THREAD

View More Details +

Engaging Patients in Decentralized Clinical Trials: Best Practices
4:00pm GMT / 5:00 pm CET / 11:00am EST

  • The dire need for clinical trial participation
  • Physical Barriers to clinical trial participation
  • Emotional drivers impacting trial participation fear
  • Changing the game on clinical trial recruiting
  • Measuring outcomes

Speaker:

Ricki Fairley
Chief Executive Officer
TOUCH
The Black Breast Cancer Alliance, USA

View More Details +

DAY 4 – 18 NOVEMBER 2021



Place-shifting, Leveraging Digitalisation as an Enabler of Hybrid and Remote Trials
2:00pm GMT / 3:00pm CET / 9:00am EST

  • Common technology components of DCTs
  • Designing studies with effective measurement strategies that can be implemented in a decentralized fashion
  • The use of wearables and sensors to develop and deliver novel clinical endpoints – how do we leverage and accelerate this
  • The challenge of data aggregation and data management with a growing number of data sources
  • Enabling CRA activities with remote trial tools

Speaker:

Bill Byrom, PhD
VP Product Intelligence and Positioning
Signant Health

View More Details +

Supporting Patients to Reduce Burden and Improve Compliance
3:00pm GMT / 4:00 pm CET / 10:00 am EST

This webcast will focus on the services available to clinical trial patients to increase retention and compliance while reducing patient burden. Scout Clinical provides a full range of patient services in a flexible model to meet the needs of patients wherever they are. Services include data-triggered payments associated with milestones, virtual visit completion stipends or prepaid local lab visits.

Speaker:

Matt Sowards
CIO
Scout Clinical

View More Details +

Expanding Upon the Utility and Versatility of Decentralized Clinical Trials Through the Use of Digital Endpoints
4:00pm GMT / 5:00 pm CET / 11:00am EST

  • The utility of DCT in the cardiovascular / HF space
  • What measures would be applicable in the space while providing key information about patients
  • The utility of wearables/biosensors as they relate to cardiovascular disease
  • How one would go about analysing such data
  • The benefit of introducing these approaches and adapting DCTs for cardiovascular trials moving forward

Speaker:

Vanja Vlajnic
Sr. Manager
Statistics and Data Insights
Bayer Science Fellow, Bayer U.S. LLC, USA

View More Details +

REGISTER NOW – Please select the webcast(s) you wish to attend and enter your contact details

DAY 1 – 15 NOVEMBER, 2021

DAY 2 – 16 NOVEMBER, 2021

DAY 3 – 17 NOVEMBER, 2021

DAY 4 – 18 NOVEMBER, 2021